| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/24/2010 | US20100160259 Dosage regimen for a s1p receptor agonist |
| 06/24/2010 | US20100160245 Quercetin-Containing Compositions |
| 06/24/2010 | US20100160240 Treatment for epilepsy |
| 06/24/2010 | US20100160238 TGFP-CAP Peptide and its Uses |
| 06/24/2010 | US20100160225 Lefty, lefty derivatives and uses thereof |
| 06/24/2010 | US20100159589 Nestin-expressing hair follicle stem cells |
| 06/24/2010 | US20100159043 Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same |
| 06/24/2010 | US20100159034 Pyrrolidinone inhibitors of pde-4 |
| 06/24/2010 | US20100159033 Benzisoxazole modulators of d2 receptor, and/or 5-ht2a receptor |
| 06/24/2010 | US20100159032 Combinations useful for the treatment of neuronal disorders |
| 06/24/2010 | US20100159025 Systemically and locally administered cells for neuropathic pain |
| 06/24/2010 | US20100159005 COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS |
| 06/24/2010 | US20100159004 Methods and compositions for reduction of side effects of therapeutic treatments |
| 06/24/2010 | US20100158995 Systems for delivery and release of angiotensin-(1-7) |
| 06/24/2010 | US20100158988 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 06/24/2010 | US20100158956 Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement |
| 06/24/2010 | US20100158950 Use of tetanus toxin to amplify inadequate voluntary muscle contraction or to improve muscle tone in an animal actively vaccinated against the toxin and a regimen for treatment |
| 06/24/2010 | US20100158923 Reducing polyglutamine-based aggregation |
| 06/24/2010 | US20100158918 Polypeptides and polynucleotides encoding same |
| 06/24/2010 | US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders |
| 06/24/2010 | US20100158889 Enhancing the effect of therapeutic proteins on the central nervous system |
| 06/24/2010 | US20100158880 Regeneration and repair of neural tissue following injury |
| 06/24/2010 | US20100158878 Target populations of oligodendrocyte precursor cells and methods of making and using same |
| 06/24/2010 | US20100158869 Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 06/24/2010 | US20100158807 Receptor |
| 06/24/2010 | DE102008064588A1 Nahrungsergänzungsmittel auf der Basis von Pantothensäure Food supplements based on pantothenic acid |
| 06/24/2010 | DE102008064061A1 Feste Zusammensetzung mit dem Wirkstoff Rasagilin A solid composition containing the active ingredient rasagiline |
| 06/24/2010 | DE102008061247A1 Inhibitoren der Dimethylarginin Dimethylaminohydrolase Inhibitors of dimethylarginine dimethylaminohydrolase |
| 06/24/2010 | CA2747803A1 [2.2.2] bicyclic derivatives and methods of use |
| 06/24/2010 | CA2747758A1 Regeneration and repair of neural tissue following injury |
| 06/24/2010 | CA2747715A1 Thiazolopyridine sirtuin modulating compounds |
| 06/24/2010 | CA2747365A1 Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof |
| 06/24/2010 | CA2747359A1 Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof |
| 06/24/2010 | CA2746990A1 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives |
| 06/24/2010 | CA2744935A1 New compounds |
| 06/24/2010 | CA2742914A1 Substituted bicyclic imidazole derivatives as gamma secretase modulators |
| 06/23/2010 | EP2199293A1 One-step process for preparing paliperidone and its oxalate salt |
| 06/23/2010 | EP2199292A1 7-azaindirubins, 7'-azaindirubins, 7-7'-diazaindirubin and the corresponding 3'-oxime ether derivates: production thereof, their production and use as a medicament |
| 06/23/2010 | EP2199284A1 Pharmaceutical composition for inhibiting accumulation of amyloid- beta protein |
| 06/23/2010 | EP2199282A1 Amide compound |
| 06/23/2010 | EP2199274A1 Co-crystals of tramadol and paracetamol |
| 06/23/2010 | EP2198922A1 CNS chloride modulation and uses thereof |
| 06/23/2010 | EP2198877A2 Orally administered peptides to ameliorate atherosclerosis |
| 06/23/2010 | EP2198874A1 Therapeutic compositions designed for treating depression |
| 06/23/2010 | EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors |
| 06/23/2010 | EP2198864A1 Pharmaceutical compositions having an analgesic effect and containing 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino propionic acid amides or related compounds |
| 06/23/2010 | EP2198856A1 Process for preparing granular compositions |
| 06/23/2010 | EP2197914A1 HUMANIZED ANTIBODIES AGAINST THE ß-AMYLOYD PEPTIDE |
| 06/23/2010 | EP2197877A1 3-methyl-2- ( (2s) -2- (4- (3-methyl-l, 2, 4-0xadiaz0l-5-yl) phenyl) morpholino) -6- (pyrimidin-4-yl) pyrimidin-4 (3h) -one as tau protein kinase inhibitor |
| 06/23/2010 | EP2197852A1 Spiro-condensed imidazolone derivatives inhibiting the glycine transporter |
| 06/23/2010 | EP2197843A1 Piperidine derivatives as agonists of muscarinic receptors |
| 06/23/2010 | EP2197838A1 Novel phenylurea derivatives, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 06/23/2010 | EP2197478A1 Use of glp-1 analogues for the treatment of disorders associated with dysfunctional synaptic transmission |
| 06/23/2010 | EP2197477A2 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 06/23/2010 | EP2197475A2 Use of gip for the treatment of disorders associated with dysfunctional synaptic transmission |
| 06/23/2010 | EP2197470A2 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections |
| 06/23/2010 | EP2197466A2 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
| 06/23/2010 | EP2197462A2 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent |
| 06/23/2010 | EP2197450A1 7-keto dhea for psychiatric use |
| 06/23/2010 | EP2197441A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 06/23/2010 | EP2197436A1 Preparation and a component intended to be added to a tobacco product |
| 06/23/2010 | EP2197435A1 Novel nutraceutical compositions containing thymol and/or p-cymene or plant extracts for cognition |
| 06/23/2010 | EP1781276B1 Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain |
| 06/23/2010 | EP1511735B1 Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors |
| 06/23/2010 | CN1994426B Preparation method, and identification and assaying method of 'Sheng Mai' soft capsule |
| 06/23/2010 | CN1990035B Paraplegia treating Chinese traditional medicine and preparation method thereof |
| 06/23/2010 | CN1930123B Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 06/23/2010 | CN1906173B Protein modifier production inhibitor |
| 06/23/2010 | CN1870980B Controlled release sterile injectable aripiprazole formulation and method |
| 06/23/2010 | CN1821236B Therapeutic heterocyclic compounds |
| 06/23/2010 | CN1620304B Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes |
| 06/23/2010 | CN1446100B Method for treating movement disorder |
| 06/23/2010 | CN101754960A Tetrahydropyranochromene gamma secretase inhibitors |
| 06/23/2010 | CN101754762A Formulations containing pyrid azine compound field of invention |
| 06/23/2010 | CN101754758A A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease |
| 06/23/2010 | CN101754756A Novel compositions comprising a phosphodiesterase-5 inhibitor and their use in methods of treatment |
| 06/23/2010 | CN101754752A Extended release formulations comprising quetipine and methods for their manufacture |
| 06/23/2010 | CN101748096A Sub totipotential stem cell and preparation method and application thereof |
| 06/23/2010 | CN101747410A Aminoacyl tyrosyl tryptophan tripeptide with easing pain activity and preparation method and application thereof |
| 06/23/2010 | CN101747324A Sulfonamide derivatives |
| 06/23/2010 | CN101747280A Method for preparing detomidine and the intermediate thereof |
| 06/23/2010 | CN101747274A Method for preparing crystal form A of blonanserin |
| 06/23/2010 | CN101747272A Crystal form B of blonanserin and preparing method thereof |
| 06/23/2010 | CN101747215A Method for preparing meclofenoxate hydrochloride sterile bulk drug |
| 06/23/2010 | CN101747170A Conjugated type coenzyme Q analogue, preparation method and application thereof |
| 06/23/2010 | CN101745176A Brain refreshing and eyesight improving health care bag |
| 06/23/2010 | CN101745118A Cell cytokine for treatment of Alzheimer |
| 06/23/2010 | CN101745098A Application of nerve polypeptide PACAP38 in the preparation of eye disease curing, injury repair or reproduction drugs |
| 06/23/2010 | CN101745097A Alpha-conotoxins from Hainan province for specific blockage of acetylcholine receptor and application thereof |
| 06/23/2010 | CN101745096A Combined medicament of brain protein hydrolysate |
| 06/23/2010 | CN101745094A Medical application of MyD88 topological peptide compounds used as immunosuppressant |
| 06/23/2010 | CN101745087A Composition with effects of relieving alcoholism and preventing drunkenness and preparation method thereof |
| 06/23/2010 | CN101745084A Chinese herba preparation used for rehabilitation of central lesion |
| 06/23/2010 | CN101745066A Medicine for treating senile dementia and preparation method thereof |
| 06/23/2010 | CN101745065A Pharmaceutical composition with effects of resisting cancer and alleviating pain |
| 06/23/2010 | CN101745064A Cancer pain killing paste |
| 06/23/2010 | CN101745050A Uygur medicine for steam treatment |
| 06/23/2010 | CN101745042A Composition with effects of relieving alcoholism and protecting liver and preparation method thereof |
| 06/23/2010 | CN101745025A Method for preparing brain-nourishing capsule oral solid preparation |
| 06/23/2010 | CN101744969A Medicinal composition for treating insomnia and preparation method thereof |